Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
07/2012
07/18/2012CN102596224A Use of mimotopes of alpha-synuclein epitopes for treating lewy body diseases
07/18/2012CN102596221A Immunological targeting of pathological TAU proteins
07/18/2012CN102596219A Novel bacteriophage and antibacterial composition comprising the same
07/18/2012CN102590515A Clostridium difficile exotoxin A test kit and monoclonal antibodies therein
07/18/2012CN102590508A Immunochromatographic strip for detecting viscerotropic leishmania infection and diagnosing kala-azar
07/18/2012CN102586311A Enterohemorrhage Escherichia coli (EHEC) O157:H7 multivalence fliC-hcpA-tir-eae recombinant strain and vaccine
07/18/2012CN102586287A HPV16L1 polynucleotide sequence and expression vector, host cell and application thereof
07/18/2012CN102586263A Large yellow croaker interleukin-1beta (IL-1beta) gene cloning method and application thereof
07/18/2012CN102586199A Defective influenza virus particles
07/18/2012CN102586196A H1N1 subtype swine influenza virus and application thereof
07/18/2012CN102586195A Method for preparing avian influenza virus and inactivated vaccine thereof with Vero passage cells
07/18/2012CN102586194A H9 subtype avian influenza virus Vero cell adapted strain and application thereof
07/18/2012CN102586166A Construction of recombinant bacteria expressing avian encephalomyelitis virus VP1 protein
07/18/2012CN102585004A AEG-1 (Astrocyte Elevated Gene-1)/1E3 monoclonal antibody with high affinity
07/18/2012CN102585002A High affinity antibodies to human il-6 receptor
07/18/2012CN102585001A Anti-mn antibodies and methods of using same
07/18/2012CN102584998A Canine thymic stromal lymphopoietin protein and uses thereof
07/18/2012CN102584997A Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
07/18/2012CN102584994A Egg yolk antibody for curing colibacillosis and preparation method thereof
07/18/2012CN102584992A Colon bacillus outer membrane protein monoclonal antibody and preparation method and application thereof
07/18/2012CN102584966A Recombinant peanut allergen and mutant and preparation method and application of recombinant peanut allergen and mutant
07/18/2012CN102584949A Pc-C polypeptide inhibiting aspergillus fumigatus from adhering to cornea
07/18/2012CN102584947A Antibodies directed against hepatitis c virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions
07/18/2012CN102584943A Vascular smooth muscle L type calcium ion channel immunogenic peptide and application thereof
07/18/2012CN102583460A Aluminium adjuvant as well as preparation method and application thereof
07/18/2012CN102580118A Preparation method of shiga-like toxin Stx1B oral vaccine and product of shiga-like toxin Stx1B oral vaccine
07/18/2012CN102580116A Duck virus hepatitis suicide DNA vaccine, as well as constructing method and application thereof
07/18/2012CN102580115A Tuberculosis mucosa gene vaccine assembled by using chitosan oligosaccharide delivery system and preparation and application of tuberculosis mucosa gene vaccine
07/18/2012CN102580103A Thermal protective agent and vaccine containing thermal protective agent
07/18/2012CN102580089A High-titer hepatitis B immunized plasma and preparing process thereof
07/18/2012CN102580088A Egg yolk antibody for treating porcine circovirus disease and method for producing compound thereof
07/18/2012CN102580087A In-situ adipocyte composite inhibitor for local weight loss and body care of human bodies and preparation method thereof
07/18/2012CN102580086A Treatment of cancer with anti-IL-1[alpha] antibodies
07/18/2012CN102580085A Application of VEGF (Vascular Endothelial Growth Factor) receptor fusion protein in preparation of medicament treating sepsis
07/18/2012CN102580084A Fixed dosing of HER antibodies
07/18/2012CN102580083A Method for preparing nanoparticle oil adjuvant vaccine
07/18/2012CN102580082A Inactived vaccine for poultry and preparation method thereof
07/18/2012CN102580081A NAD (Nicotinamide Adenine Dinucleotide), aluminum hydroxide compound adjuvant and vaccine containing compound adjuvant
07/18/2012CN102580080A Method for preparing newcastle disease and infectious bronchitis virus solution
07/18/2012CN102580079A Porcine parvovirus nanometer alumina gel adjuvant inactivated vaccine and preparation method thereof
07/18/2012CN102580078A Design and preparation method of HIV-CRF 07BC gp41 polypeptide vaccine
07/18/2012CN102580077A Intranasal influenza vaccine based on virosomes
07/18/2012CN102580076A Synthetic peptide vaccine for O-type foot and mouth disease of swine and preparation method thereof
07/18/2012CN102580075A Divalent combined oil-emulsion inactivated vaccine for preventing goat contagious pleuropneumonia and preparation method
07/18/2012CN102580074A Riemerella anatipestifer-escherichia coli outer membrane protein bivalent vaccine and preparation method thereof
07/18/2012CN102580073A Polysaccharide and protein conjugate
07/18/2012CN102580072A Combination neisserial compositions
07/18/2012CN102580071A Preparation method of toxin subunit inactivated vaccine for preventing piglet edema disease
07/18/2012CN102580070A Compositions for Immunizing Against Mycobacterium
07/18/2012CN102580069A Eye-drop vaccine containing copolymer 1 for therapeutic immunization
07/18/2012CN102579339A Oil emulsion vaccine for broilers and preparation method thereof
07/18/2012CN102127533B Preparation method of recombinant porcine circovirus type 2 Cap antigen
07/18/2012CN101979581B S7 gene and coded recombinant protein of grass carp reovirus strain, and acquisition method and application thereof
07/18/2012CN101792743B Recombinant baculovirus expressing porcine circovirus type 2 (PCV-2) immunogen gene and preparation method and application thereof
07/18/2012CN101735310B Human papilloma virus (HPV) fusion protein, gene, carrier, strain, preparation method and application
07/18/2012CN101703771B Oil-in-water type compound vaccine adjuvant and method for preparing same
07/18/2012CN101693105B Application of IL-4-like recombinant protein of fishes
07/18/2012CN101687026B Mutated e. coli heat-labile enterotoxin
07/18/2012CN101531717B Anti-Alzheimer disease monoclonal antibody and application thereof
07/18/2012CN101511871B Anti-myostatin antibodies
07/18/2012CN101243104B Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system
07/18/2012CN101240022B Cell proliferation inhibitors containing anti-glypican 3 antibody
07/18/2012CN101180079B Multivalent pneumococcal polysaccharide-protein conjugate composition
07/18/2012CN101128597B Use of an agent produced from a parasite for prevention and control of diseases
07/18/2012CN101039960B Chimeric and humanised monoclonal antibodies against interleukin-13
07/17/2012US8222398 Chimeric immunomodulatory compounds and methods of using the same-II
07/17/2012US8222393 Using U7 polypeptide as diagnostic and therapeutic tool preventing and treating cell proliferative disorders
07/17/2012US8222392 Kit for detection of telomerase reverse transcriptase nucleic acids
07/17/2012US8222376 KIR-binding agents and methods of use thereof
07/17/2012US8222375 Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies
07/17/2012US8222374 IL-21 antagonists
07/17/2012US8222373 Humanized antibodies and compositions for binding sphingosine-1-phosphate
07/17/2012US8222370 Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof
07/17/2012US8222036 Oncolytic viruses as phenotyping agents for neoplasms
07/17/2012US8222002 Human anti-amyloid beta peptide antibody and fragment of said antibody
07/17/2012US8221988 Methods and compositions relating to CCR5 antagonist, IFN-γ and IL-13 induced inflammation
07/17/2012US8221969 Method of producing virus
07/17/2012US8221770 Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-neisseria meningitidis
07/17/2012US8221769 Microorganisms for therapy
07/17/2012US8221768 Chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence
07/17/2012US8221764 Secreted campylobacter flagella coregulated proteins as immunogens
07/17/2012US8221763 Yeast-antigen compositions and methods of using the same
07/17/2012US8221762 Naturally processed measles virus peptides from class II HLA molecules
07/17/2012US8221761 Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing CG motifs
07/17/2012US8221760 Methods of treatment using human anti-IL-23 antibodies
07/17/2012US8221759 Neutralizing monoclonal antibodies to respiratory syncytial virus
07/17/2012US8221758 Anti-midkine antibody for preventing post-laparotomy adhesions
07/17/2012US8221757 Monoclonal antibodies against extracellular loops of C5aR
07/17/2012US8221756 Complement inhibitors and uses thereof
07/17/2012US8221755 Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ralpha1)
07/17/2012US8221754 Antihuman α9 integrin antibody and use of the same
07/17/2012US8221753 Endoglin antibodies
07/17/2012US8221752 Antibodies against human interleukin-13 and uses therefor
07/17/2012US8221751 Tumor-targeting monoclonal antibodies to FZD10 and uses thereof
07/17/2012US8221750 Single chain antibodies against β-amyloid peptide
07/17/2012US8221749 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
07/17/2012US8221748 Compositions and methods for the systemic treatment of arthritis
07/17/2012US8221741 Methods for modulating inflammatory and/or immune responses
07/17/2012CA2666492C Stable polypeptide formulations
07/17/2012CA2659917C Encapsulated vaccines for the oral vaccination and boostering of fish and other animals